<DOC>
	<DOCNO>NCT01366287</DOCNO>
	<brief_summary>The primary purpose study estimate relative bioavailability food effect PF-03882845 tablet compare suspension formulation use previous clinical study .</brief_summary>
	<brief_title>A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its Absorption</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Healthy male and/or female subject age 18 55 year , Females must nonchildbearing potential . Body mass index 17.5 30.5 kg/m2 . Subjects willing able comply schedule visit , treatment plan , laboratory test , study procedure . Serum potassium &gt; 5 mEq/L screening . Impaired kidney function ( estimate GFR &lt; 60 mL/min/1.73 m2 ) . History sensitivity eplerenone , spironolactone , related compound .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Relative bioavailability</keyword>
	<keyword>food effect</keyword>
	<keyword>tablet</keyword>
	<keyword>suspension</keyword>
	<keyword>single dose</keyword>
	<keyword>crossover</keyword>
	<keyword>healthy subject</keyword>
</DOC>